Skip to Content
Merck
All Photos(1)

Documents

Y0000405

Salicylic acid impurity B

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

4-Hydroxyisophthalic acid, 4-Hydroxy 1,3-benzenedicarboxylic acid

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
HOC6H3-1,3-(CO2H)2
CAS Number:
Molecular Weight:
182.13
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

salicylic acid

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

OC(C1=CC(C(O)=O)=C(O)C=C1)=O

InChI

1S/C8H6O5/c9-6-2-1-4(7(10)11)3-5(6)8(12)13/h1-3,9H,(H,10,11)(H,12,13)

InChI key

BCEQKAQCUWUNML-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Salicylic acid impurity B EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

[In vitro study of the effects of various 4-hydroxyisophthalic acid derivatives on human platelet aggregation].
M De Cunto et al.
Bollettino della Societa italiana di biologia sperimentale, 59(3), 302-308 (1983-03-30)
[In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
M Berrettini et al.
Bollettino della Societa italiana di biologia sperimentale, 59(3), 309-315 (1983-03-30)
E Piscopo et al.
Bollettino della Societa italiana di biologia sperimentale, 60(12), 2273-2279 (1984-12-30)
A series of 1,3 -bis-anilides of 4-hydroxyisophthalic acid was prepared and tested for antibacterial and antifungal activity. The prepared compounds (I-XVIII), of general structure (A), (Formula: see text) where Xn = H (I); 2-F (II); 3-F (III); 4-F (IV); 2-Cl
C P Saint et al.
FEMS microbiology letters, 57(3), 323-328 (1990-06-01)
Genes involved in 4-methyl-o-phthalate and 4-hydroxy-iso-phthalate catabolism reside on a 226-232 kbp catabolic plasmid termed MOP. This was confirmed by transformation and conjugation into an isogenic heat-cured (MOP-) derivative of the wild-type isolate, identified and termed Pseudomonas cepacia Pc701. Transformation
E Piscopo et al.
Bollettino della Societa italiana di biologia sperimentale, 60(6), 1169-1175 (1984-06-30)
The following hydrazono derivatives (I-XIX) of type (A) (sequence in text) where Rn = (sequence in text ) (I-XVII); (sequence in text) (XVIII); -CCl3 (XIX); and Xn = H (I); 2-Cl (II); 3-Cl (III); 4-Cl (IV); 2-NO2 (V); 3-NO2 (VI);

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service